RecruitingNCT07257094

Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

Sponsor

Hôpital NOVO

Enrollment

346 participants

Start Date

Jan 10, 2026

Study Type

OBSERVATIONAL

Conditions

Carcinoma

Summary

This study aims to validate a French version of the Nasal Reconstruction FACE-Q questionnaire for patients who have undergone nasal reconstruction or prosthetic rehabilitation after surgery for nasal skin cancer. The questionnaire evaluates appearance, quality of life, and possible side effects related to the reconstruction. The investigators hypothesize that the validated French version will provide a reliable and standardized tool to assess patient satisfaction and health-related quality of life in this context.

Eligibility

Min Age: 18 Years

Inclusion Criteria13

PATIENTS
Age ≥ 18 years
Patient who has undergone excision of a cutaneous, mucocutaneous, or vestibular nasal cancer with surgical reconstruction using a flap or prosthetic rehabilitation, performed more than 4 months ago, with stable results, and less than 3 years ago
Patient informed of the study and not opposed to participation
Age ≥ 65 years
Subject informed and not opposed to participating in the study
Subject who has never undergone facial trauma or surgery, and without major comorbidity, defined as follows:
No heart failure (moderate or severe heart failure, history of heart attack within the last 6 months);
No severe chronic respiratory disease (no stage III-IV COPD, no prolonged oxygen therapy);
No uncontrolled diabetes or associated severe complications;
No active immunosuppressive diseases or high-dose immunosuppressive treatment;
No unstable or severe facial dermatological conditions;
No comorbidities seriously affecting quality of life or respiratory function (at the investigator's discretion).

Exclusion Criteria9

Patient under anticoagulant or antiplatelet therapy Non-French-speaking patient
Patient under legal protection (e.g., guardianship, legal safeguard) or with limited legal capacity
Patient unlikely to cooperate with the study and/or poor anticipated compliance as judged by the investigator (including psychiatric disorders other than depressive disorder or cognitive impairment)
Pregnant or breastfeeding woman
CONTROL
Non-English speaking subject
Subject under guardianship or legal protection, legally incompetent or with limited legal capacity
Subject unlikely to cooperate in the study and/or anticipated low cooperation by the investigator (particularly those with psychiatric disorders other than depression or cognitive disorders)
Pregnant or breastfeeding women

Interventions

OTHERoperated patients

Response to the Nasal Reconstruction FACE-Q questionnaire, which includes the following scales : * Appearence : Face overall, nose, nostrils, skin * Health related quality of life (HRQOL) : Early life impact, psychological, social, outcome * Adverse effects : on the nose, on the forehead, eyebrows and scalp * Nasal Obstruction Symptom Evaluation (NOSE) * Short-Form-36 (SF 36)

OTHERControl

Response to the Nasal Reconstruction FACE-Q questionnaire, which includes the following scales : * Appearence : Face overall, nose, nostrils, skin impact psychological, impact social, * SF36